Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)

European Journal of Haematology

Volumn 86, Issue 3, 2011, Pages 274-275

  Vini, Dimitra ^a   Servos, Philippos ^a   Drosou, Marouso ^a  

^a Thalassaemia Unit   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; DEFEROXAMINE MESYLATE;

ADULT; CASE REPORT; CONSTIPATION; DRUG ERUPTION; DRUG WITHDRAWAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; LABORATORY TEST; LETTER; PREGNANCY; PRIORITY JOURNAL; SPLENECTOMY; THALASSEMIA MAJOR;

ADULT; BENZOIC ACIDS; BETA-THALASSEMIA; FEMALE; HUMANS; INFANT, NEWBORN; IRON CHELATING AGENTS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; TRIAZOLES;

EID: 79951682677     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01569.x     Document Type: Letter

References (11)

1. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR. Complications of β-thalassemia major in North America. Blood 2004;104:34-9.
2. Ansari S, Azarkeivan A, Tabaroki A. Pregnancy in patients treated for beta thalassemia major in two centers (Ali Asghar Children's Hospital and Thalassemia Clinic): outcome for mothers and newborn infants. Pediatr Hematol Oncol 2006;23:33-7.
3. Mordel N, Birkenfeld A, Goldfarb AN, Rachmilewitz EA. Successful full-term pregnancy in homozygous beta-thalassemia major: case report and review of the literature. Obstet Gynecol 1989;73:837-40.
4. Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M. Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab 1998;11(Suppl 3):935-43.
5. Protonotariou AA, Tolis GJ. Reproductive health in female patients with beta-thalassemia major. Ann NY Acad Sci 2000;900:119-24.
6. Tampakoudis P, Tsatalas C, Mamopoulos M, Tantanassis T, Christakis JI, Sinakos Z, Mantalenakis S. Transfusion-dependent homozygous beta-thalassaemia major: successful pregnancy in five cases. Eur J Obstet Gynecol Reprod Biol 1997;74:127-31.
7. Vaskaridou E, Konstantopoulos K, Kyriakou D, Loukopoulos D. Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases. Haematologica 1993;78:183-4.
8. Karagiorga-Lagana M. Fertility in thalassemia: the Greek experience. J Pediatr Endocrinol Metab 1998;11(Suppl 3):945-51.
9. Jensen CE, Tuck SM, Wonke B. Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol 1995;102:625-9.
10. Pearson HA. Iron studies in infants born to an iron overloaded mother with beta-thalassemia major: possible effects of maternal desferrioxamine therapy. J Pediatr Hematol Oncol 2007;29:160-2.
11. Singer ST, Vichinsky EP. Deferoxamine treatment during pregnancy: is it harmful? Am J Hematol 1999;60:24-6.